Loading…
Agropharm (აგროფარმა) — a Georgian importer and exclusive distributor of agricultural inputs: plant-protection products, fertilizers, seed material and farm inventory, representing European, Asian and American manufacturers (agropharm.ge). An agriculture-inputs business, not a human-pharma company.
| Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 24.5% | 26.8% | 32.3% | 43.6% |
| EBITDA Margin | 19.6% | 22.9% | 23.8% | 33.9% |
| EBITDAR | 1,171 | 2,873 | 2,247 | 3,038 |
| EBITDAR Margin | 19.8% | 23.1% | 24.3% | 34.5% |
| EBIT Margin | 19.6% | 22.8% | 23.6% | 33.5% |
| Net Profit Margin | 20.1% | 21.7% | 23.7% | 36.8% |
| Operating Expense % of Sales | 4.9% | 3.9% | 8.4% | 9.7% |
| Returns | ||||
| Return on Assets (ROA) | 38.2% | 31.4% | 25.7% | 31.5% |
| Return on Equity (ROE) | 100.0% | 69.4% | 36.1% | 36.3% |
| ROIC [EBIT / Invested Capital] | 43.1% | 51.6% | 53.2% | 57.5% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 58.5% | 47.4% | 26.4% | 10.0% |
| Debt-to-Equity | 1.53x | 1.05x | 0.37x | 0.12x |
| Debt-to-EBITDA | 1.57x | 1.43x | 1.02x | 0.35x |
| Equity-to-Assets | 38.2% | 45.3% | 71.1% | 86.9% |
| Net Debt | 1,499 | 1,596 | -1,975 | -3,814 |
| Cash & Equivalents | 321 | 2,461 | 4,232 | 4,848 |
| Total Debt | 1,821 | 4,057 | 2,257 | 1,034 |
| Liquidity & working capital | ||||
| Current Ratio | 1.61x | 1.77x | 3.33x | 7.31x |
| Quick Ratio | 1.61x | 1.77x | 3.33x | 7.31x |
| Cash Ratio | 0.17x | 0.53x | 1.72x | 3.60x |
| Total Current Assets | 3,090 | 8,304 | 8,201 | 9,851 |
| Total Current Liabilities | 1,923 | 4,685 | 2,466 | 1,347 |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 857 | 1,595 | 1,360 | 2,598 |
| Trade Payables | 90 | 557 | 145 | 261 |
| Net Working Capital | 1,168 | 3,618 | 5,735 | 8,504 |
| Net Working Capital % of Revenue | 19.7% | 29.1% | 62.0% | 96.5% |
| Trade Working Capital | 767 | 1,038 | 1,214 | 2,336 |
| Trade Working Capital % of Revenue | 13.0% | 8.3% | 13.1% | 26.5% |
| Change in Trade Working Capital | N/A | 271 | 176 | 1,122 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 6.90x | 7.80x | 6.80x | 3.39x |
| Days Sales Outstanding (DSO) | 52.9 | 46.8 | 53.7 | 107.6 |
| Payables Turnover | 49.68x | 16.36x | 43.08x | 19.01x |
| Days Payable Outstanding (DPO) | 7.3 | 22.3 | 8.5 | 19.2 |
| Cash Conversion Cycle | 45.5 days | 24.5 days | 45.2 days | 88.4 days |
| Asset Turnover | 1.90x | 1.45x | 1.08x | 0.86x |
| Cash flow & dividends | ||||
| Operating Cash Flow | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.